objectivesth
role
bacteria
acut
respiratori
ill
ari
adult
interact
viral
infect
incomplet
understood
studi
test
hypothesi
bacteri
coinfect
ari
add
airway
inflamm
ill
sever
methodstwo
group
specimen
randomli
select
multiplexpcr
identifi
virusposit
virusneg
nasal
specimen
obtain
adult
new
onset
ari
control
specimen
collect
healthi
adult
specimen
analyz
haemophilu
influenza
hi
moraxella
catarrhali
mc
streptococcu
pneumonia
sp
quantitativepcr
gener
linear
model
test
relationship
respiratori
pathogen
biomark
nasal
wash
neutrophil
arisever
resultsnas
specimen
adult
ari
like
contain
bacteria
overal
compar
specimen
healthi
adult
overal
p
among
ari
specimen
bacteria
like
detect
among
virusneg
specimen
compar
virusposit
specimen
vs
presenc
bacteria
significantli
associ
increas
neutrophil
increas
symptom
conclusionpathogen
bacteria
often
detect
virusneg
ari
also
associ
increas
inflammatori
biomark
find
suggest
possibl
bacteria
may
augment
virusinduc
ari
contribut
airway
inflamm
summaryw
test
whether
bacteri
pathogen
associ
ari
ill
inflamm
bacteria
detect
often
nasal
secret
ari
especi
sampl
without
detect
virus
associ
increas
airway
inflamm
increas
symptom
virus
major
caus
acut
respiratori
infect
ari
adult
children
ari
includ
influenza
common
cold
worldwid
problem
account
signific
loss
product
financi
burden
healthcar
system
although
variou
experiment
epidemiolog
studi
identifi
virus
pathogen
ari
signific
number
ari
episod
unknown
etiolog
despit
improv
diagnost
procedur
suggest
bacteri
pathogen
haemophilu
influenza
streptococcu
pneumonia
moraxella
catarrhali
contribut
ari
howev
result
studi
inconclus
detect
bacteria
increas
symptomat
children
adult
compar
healthi
control
studi
involv
ari
suffer
heald
et
al
report
posit
bacteria
cultur
nasopharyng
secret
adult
ari
ill
found
bacteria
healthi
control
howev
winther
et
al
found
differ
nasal
bacteri
healthi
ari
ill
condit
even
antibiot
often
prescrib
uncompl
ari
widespread
inappropri
use
antibiot
contribut
emerg
antibiot
resist
therefor
increas
health
care
cost
evid
virusinduc
inflamm
contribut
respiratori
symptom
cours
viral
ill
signific
correl
level
neutrophil
count
nasal
secret
cold
symptom
sever
evid
detect
bacteri
pathogen
ari
may
associ
increas
inflammatori
biomark
given
find
hypothes
viral
ari
detect
specif
bacteri
pathogen
would
associ
increas
level
inflammatori
biomark
greater
measur
sever
ill
secondari
goal
examin
nasal
secret
pathogen
bacteria
ari
adult
suffer
without
detect
virus
rational
stratifi
analysi
determin
bacteri
coinfect
would
lead
greater
ari
ill
sever
compar
viral
pathogen
detect
stratif
enabl
us
determin
whether
symptom
greater
bacteria
plu
viru
vs
viru
alon
also
determin
whether
symptom
greater
bacteria
alon
compar
pathogen
detect
control
group
also
evalu
frequenc
bacteria
nasal
wash
specimen
healthi
adult
final
assess
relationship
respiratori
pathogen
inflammatori
biomark
selfreport
sever
ill
studi
protocol
approv
univers
wisconsinmadison
institut
review
board
ari
specimen
obtain
subset
particip
nihsponsor
random
clinic
trial
physician
echinacea
placebo
pep
studi
total
nasal
wash
specimen
obtain
adult
begin
ari
test
viral
nucleic
acid
multiplex
pcr
multiplex
found
posit
viru
found
neg
studi
specimen
per
group
randomli
select
wwwrandomizerorg
group
detect
respiratori
virus
without
detect
respiratori
virus
sampl
size
select
base
test
hypothes
differ
bacteri
detect
rate
effect
size
pep
trial
span
januari
august
enrol
particip
complet
studi
one
particip
miss
viral
nucleic
acid
result
studi
rational
method
describ
previous
briefli
pill
arm
pep
trial
examin
placebo
echinacea
particip
elig
acknowledg
cold
point
jackson
symptom
scale
includ
follow
symptom
within
hour
enrol
nasal
discharg
obstruct
sneez
sorethroat
reason
exclus
includ
activ
symptom
allergi
asthma
observ
enrol
use
antibiot
exclud
medic
addit
specimen
obtain
adult
evid
cold
symptom
global
ari
sever
calcul
use
areaunderthecurv
trapezoid
approxim
durat
xaxi
symptom
score
yaxi
durat
ill
defin
time
symptom
onset
particip
respond
question
think
still
cold
symptom
score
selfreport
wisconsin
upper
respiratori
symptom
survey
consist
symptom
life
item
use
sever
estim
two
remain
item
assess
global
sever
sick
feel
today
daili
chang
ill
compar
yesterday
think
cold
assess
separ
pep
find
show
signific
betweengroup
differ
sever
durat
ill
treatment
group
nasal
wash
specimen
also
analyz
neutrophil
describ
previous
pathogen
detect
viral
pathogen
nasal
secret
collect
identifi
use
multiplex
pcr
respiratori
multicodeplx
assay
eragen
bioscienc
madison
wi
assay
detect
common
respiratori
virus
includ
rhinoviru
coronaviru
influenza
respiratori
syncyti
viru
parainfluenza
viru
adenoviru
bocaviru
metapneumoviru
enteroviru
nasal
wash
specimen
analyz
specif
bacteri
pathogen
dna
extract
nasal
wash
specimen
biostic
bacteremia
dna
isol
kit
mo
bio
laboratori
carlsbad
ca
prevent
potenti
degrad
bacteria
dna
edta
ad
sampl
quantit
pcr
perform
h
influenza
catarrhali
pneumonia
detect
rang
bacterium
million
colonyform
unit
cfu
standard
curv
consist
dna
extract
bacteria
assay
use
mcfarland
techniqu
multiplex
qpcr
employ
copb
gene
use
detect
h
influenza
catarrhali
respect
pcr
lyta
conduct
separ
detect
pneumonia
primer
probe
purchas
appli
biosystem
foster
citi
ca
differ
bacteri
preval
test
use
chisquar
test
gener
linear
model
glm
use
examin
relationship
pathogen
neutrophil
sever
ill
boxcox
transform
use
normal
highli
skew
distribut
biomark
neutrophil
count
squareroot
transform
employ
normal
distribut
wurss
sever
score
natur
log
ln
transform
use
normal
distribut
biomark
lambda
neutrophil
covari
includ
age
gender
season
year
spring
summer
fall
winter
statist
program
use
analys
nasal
wash
specimen
obtain
total
healthi
adult
particip
acut
cold
tabl
averag
age
incom
proport
colleg
educ
higher
among
healthi
group
compar
ari
group
sampl
symptomat
particip
collect
fall
winter
spring
summer
season
year
sampl
healthi
adult
collect
augustseptemb
among
viru
posit
specimen
common
viral
agent
rhinoviru
coronaviru
ninetyf
percent
group
contain
one
type
viru
remain
contain
two
differ
virus
frequenc
bacteri
detect
significantli
greater
among
particip
ari
ill
sampl
compar
healthi
particip
sampl
p
among
nasal
specimen
symptomat
adult
bacteria
detect
significantli
often
virusneg
sampl
compar
virusposit
vs
overal
subject
ari
regardless
viral
etiolog
hinfluenza
identifi
nasal
specimen
catarrhali
pneumonia
bacteri
detect
vari
depend
presenc
viru
figur
virusneg
specimen
like
bacteri
pathogen
detect
overal
includ
hinfluenza
catarrhali
pneumonia
compar
virusposit
nasal
specimen
overal
includ
hinfluenza
catarrhali
pneumonia
within
ari
group
sever
ill
mean
confid
interv
similar
bacteria
combin
bacteria
viru
viru
pathogen
adjust
age
gender
season
year
significantli
alter
trend
tabl
addit
pattern
pathogen
detect
associ
differ
individu
rhiniti
symptom
result
shown
detect
bacteri
pathogen
associ
higher
level
greater
number
neutrophil
tabl
combin
viru
bacteria
highest
level
mean
ci
neutrophil
count
significantli
differ
compar
viral
specimen
bacteri
pathogen
caus
respiratori
ill
sinus
pneumonia
role
common
cold
controversi
test
hypothesi
bacteri
coinfect
ari
add
airway
inflamm
sever
ill
examin
frequenc
pathogen
bacteria
nasal
wash
specimen
healthi
adult
adult
ari
also
includ
exploratori
analysi
base
presenc
absenc
detect
respiratori
virus
overal
bacteria
detect
often
ill
within
ari
group
bacteri
detect
significantli
greater
among
sampl
without
detect
virus
compar
sampl
virus
furthermor
airway
inflamm
ill
sever
increas
combin
presenc
bacteri
viral
pathogen
find
suggest
bacteri
pathogen
may
contribut
subset
ari
bacteri
pathogen
may
augment
airway
inflamm
viral
ari
previou
studi
bacteri
pathogen
detect
ari
report
vari
result
support
result
han
et
al
detect
increas
bacteri
pathogen
nasal
swab
obtain
symptomat
particip
similar
find
also
report
studi
nasopharyng
wall
aspir
adult
upper
respiratori
tract
infect
studi
experiment
natur
acquir
ari
found
illnessrel
chang
bacteri
frequenc
ari
none
studi
stratifi
base
presenc
viral
pathogen
pathogen
identifi
among
group
ari
frequent
find
detect
viru
alon
consist
accept
concept
virus
common
caus
common
cold
virusneg
sampl
increas
detect
bacteria
suggest
possibl
bacteria
contribut
ill
pathogenesi
concept
also
support
result
doubleblind
random
control
trial
antibiot
treatment
ari
benefici
effect
demonstr
subgroup
particip
detect
bacteria
pathogen
analysi
sampl
posit
bacteria
viru
associ
increas
inflammatori
chang
nasal
secret
indic
greater
amount
neutrophil
despit
increas
inflamm
associ
detect
virus
plu
bacteria
sever
ill
increas
compar
ill
associ
viru
studi
ari
marker
neutrophil
inflamm
posit
correl
symptom
respiratori
ill
lack
correl
biomark
symptom
studi
may
due
rel
low
rang
ill
sever
pep
clinic
protocol
subject
select
particip
need
threshold
level
symptom
meet
elig
criteria
ill
mild
moder
sever
exclus
asymptomat
infect
limit
number
sever
infect
may
obscur
relationship
etiolog
inflamm
symptom
ill
limit
studi
includ
moder
sampl
size
homogen
popul
predominantli
caucasian
likelihood
cours
ill
could
differ
type
pathogen
strength
studi
design
includ
use
comprehens
viral
diagnost
well
pcrbase
detect
bacteri
pathogen
latter
provid
sensit
cultureindepend
diagnost
techniqu
bacteri
detect
conclus
found
higher
level
pathogen
bacteria
nasal
wash
specimen
obtain
symptomat
ari
particip
compar
healthi
adult
among
symptomat
adult
without
detect
viru
compar
viru
viral
ill
presenc
bacteria
associ
increas
inflammatori
marker
find
suggest
possibl
bacteri
pathogen
causal
subset
ari
prospect
studi
thu
warrant
better
defin
tempor
presenc
viral
bacteri
pathogen
relationship
inflamm
ill
type
bacteria
detect
acut
respiratori
infect
tabl
primer
probe
h
influenza
catarrhali
pneumonia
moraxella
catarrhali
streptococcu
pneumonia
forward
